Logo image of VYX

NCR VOYIX CORP (VYX) Stock Fundamental Analysis

NYSE:VYX - New York Stock Exchange, Inc. - US62886E1082 - Common Stock - Currency: USD

11.83  -0.09 (-0.76%)

Fundamental Rating

2

Taking everything into account, VYX scores 2 out of 10 in our fundamental rating. VYX was compared to 283 industry peers in the Software industry. While VYX is still in line with the averages on profitability rating, there are concerns on its financial health. VYX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

VYX had negative earnings in the past year.
VYX had a positive operating cash flow in the past year.
In multiple years VYX reported negative net income over the last 5 years.
VYX had a positive operating cash flow in each of the past 5 years.
VYX Yearly Net Income VS EBIT VS OCF VS FCFVYX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of 10.14%, VYX belongs to the top of the industry, outperforming 87.27% of the companies in the same industry.
The Return On Equity of VYX (36.77%) is better than 93.45% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.17%, VYX is in the better half of the industry, outperforming 73.09% of the companies in the same industry.
VYX had an Average Return On Invested Capital over the past 3 years of 4.57%. This is significantly below the industry average of 11.97%.
Industry RankSector Rank
ROA 10.14%
ROE 36.77%
ROIC 4.17%
ROA(3y)-2.57%
ROA(5y)-0.8%
ROE(3y)-46.02%
ROE(5y)-23.22%
ROIC(3y)4.57%
ROIC(5y)5.09%
VYX Yearly ROA, ROE, ROICVYX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100

1.3 Margins

VYX has a better Profit Margin (6.93%) than 72.00% of its industry peers.
The Operating Margin of VYX (2.43%) is better than 65.45% of its industry peers.
VYX's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 23.23%, VYX is doing worse than 84.36% of the companies in the same industry.
VYX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.43%
PM (TTM) 6.93%
GM 23.23%
OM growth 3Y-6.05%
OM growth 5Y-12.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y-0.8%
VYX Yearly Profit, Operating, Gross MarginsVYX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VYX is destroying value.
Compared to 1 year ago, VYX has more shares outstanding
VYX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for VYX is higher compared to a year ago.
VYX Yearly Shares OutstandingVYX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M
VYX Yearly Total Debt VS Total AssetsVYX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

2.2 Solvency

VYX has an Altman-Z score of 2.13. This is not the best score and indicates that VYX is in the grey zone with still only limited risk for bankruptcy at the moment.
VYX's Altman-Z score of 2.13 is in line compared to the rest of the industry. VYX outperforms 46.91% of its industry peers.
A Debt/Equity ratio of 0.85 indicates that VYX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.85, VYX is doing worse than 76.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Altman-Z 2.13
ROIC/WACC0.43
WACC9.65%
VYX Yearly LT Debt VS Equity VS FCFVYX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.3 Liquidity

VYX has a Current Ratio of 1.20. This is a normal value and indicates that VYX is financially healthy and should not expect problems in meeting its short term obligations.
VYX has a worse Current ratio (1.20) than 66.18% of its industry peers.
VYX has a Quick Ratio of 1.06. This is a normal value and indicates that VYX is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of VYX (1.06) is worse than 73.45% of its industry peers.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.06
VYX Yearly Current Assets VS Current LiabilitesVYX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

More info and screens

0

3. Growth

3.1 Past

The earnings per share for VYX have decreased strongly by -118.52% in the last year.
Measured over the past years, VYX shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.12% on average per year.
VYX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.50%.
The Revenue has been decreasing by -9.77% on average over the past years.
EPS 1Y (TTM)-118.52%
EPS 3Y-1.58%
EPS 5Y-9.12%
EPS Q2Q%-100%
Revenue 1Y (TTM)-13.5%
Revenue growth 3Y-14.87%
Revenue growth 5Y-9.77%
Sales Q2Q%-64.75%

3.2 Future

The Earnings Per Share is expected to decrease by -8.57% on average over the next years.
VYX is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -15.74% yearly.
EPS Next Y-118.9%
EPS Next 2Y-24.97%
EPS Next 3Y-8.57%
EPS Next 5YN/A
Revenue Next Year-24.44%
Revenue Next 2Y-24.1%
Revenue Next 3Y-15.74%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
VYX Yearly Revenue VS EstimatesVYX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B
VYX Yearly EPS VS EstimatesVYX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2 3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VYX. In the last year negative earnings were reported.
VYX is valuated correctly with a Price/Forward Earnings ratio of 12.89.
Compared to the rest of the industry, the Price/Forward Earnings ratio of VYX indicates a rather cheap valuation: VYX is cheaper than 89.09% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.65, VYX is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 12.89
VYX Price Earnings VS Forward Price EarningsVYX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VYX indicates a rather cheap valuation: VYX is cheaper than 97.82% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.08
VYX Per share dataVYX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

VYX's earnings are expected to decrease with -8.57% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.97%
EPS Next 3Y-8.57%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VYX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NCR VOYIX CORP

NYSE:VYX (2/25/2025, 3:05:53 PM)

11.83

-0.09 (-0.76%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)02-27 2025-02-27/bmo
Inst Owners104.9%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner Change-4.51%
Market Cap1.73B
Analysts80
Price Target17.17 (45.14%)
Short Float %10.82%
Short Ratio11.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP3.38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)27.12%
Min EPS beat(2)-45.76%
Max EPS beat(2)100%
EPS beat(4)2
Avg EPS beat(4)-11.93%
Min EPS beat(4)-281.76%
Max EPS beat(4)179.81%
EPS beat(8)4
Avg EPS beat(8)-0.25%
EPS beat(12)7
Avg EPS beat(12)-2.28%
EPS beat(16)9
Avg EPS beat(16)-1.23%
Revenue beat(2)1
Avg Revenue beat(2)-8.79%
Min Revenue beat(2)-19.37%
Max Revenue beat(2)1.8%
Revenue beat(4)1
Avg Revenue beat(4)-4.77%
Min Revenue beat(4)-19.37%
Max Revenue beat(4)1.8%
Revenue beat(8)3
Avg Revenue beat(8)11.07%
Revenue beat(12)4
Avg Revenue beat(12)6.53%
Revenue beat(16)5
Avg Revenue beat(16)4.6%
PT rev (1m)-1.62%
PT rev (3m)-0.98%
EPS NQ rev (1m)52.17%
EPS NQ rev (3m)169.23%
EPS NY rev (1m)0%
EPS NY rev (3m)36.9%
Revenue NQ rev (1m)-0.37%
Revenue NQ rev (3m)0.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.89
P/S 0.25
P/FCF N/A
P/OCF 345.37
P/B 1.34
P/tB N/A
EV/EBITDA 4.08
EPS(TTM)-0.6
EYN/A
EPS(NY)0.92
Fwd EY7.76%
FCF(TTM)-1.67
FCFYN/A
OCF(TTM)0.03
OCFY0.29%
SpS46.83
BVpS8.83
TBVpS-2.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.14%
ROE 36.77%
ROCE 5.27%
ROIC 4.17%
ROICexc 5.58%
ROICexgc 17.99%
OM 2.43%
PM (TTM) 6.93%
GM 23.23%
FCFM N/A
ROA(3y)-2.57%
ROA(5y)-0.8%
ROE(3y)-46.02%
ROE(5y)-23.22%
ROIC(3y)4.57%
ROIC(5y)5.09%
ROICexc(3y)4.86%
ROICexc(5y)5.43%
ROICexgc(3y)15.66%
ROICexgc(5y)15.31%
ROCE(3y)5.79%
ROCE(5y)6.44%
ROICexcg growth 3Y8%
ROICexcg growth 5Y-13.09%
ROICexc growth 3Y-3.36%
ROICexc growth 5Y-14.72%
OM growth 3Y-6.05%
OM growth 5Y-12.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y-0.8%
F-Score6
Asset Turnover1.46
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Debt/EBITDA 2.19
Cap/Depr 74.33%
Cap/Sales 3.64%
Interest Coverage 250
Cash Conversion 1%
Profit Quality N/A
Current Ratio 1.2
Quick Ratio 1.06
Altman-Z 2.13
F-Score6
WACC9.65%
ROIC/WACC0.43
Cap/Depr(3y)65.52%
Cap/Depr(5y)73.52%
Cap/Sales(3y)6.5%
Cap/Sales(5y)5.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-118.52%
EPS 3Y-1.58%
EPS 5Y-9.12%
EPS Q2Q%-100%
EPS Next Y-118.9%
EPS Next 2Y-24.97%
EPS Next 3Y-8.57%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.5%
Revenue growth 3Y-14.87%
Revenue growth 5Y-9.77%
Sales Q2Q%-64.75%
Revenue Next Year-24.44%
Revenue Next 2Y-24.1%
Revenue Next 3Y-15.74%
Revenue Next 5YN/A
EBIT growth 1Y-80%
EBIT growth 3Y-20.02%
EBIT growth 5Y-21.12%
EBIT Next Year-35.69%
EBIT Next 3Y-5.6%
EBIT Next 5YN/A
FCF growth 1Y-341.58%
FCF growth 3Y-5.7%
FCF growth 5Y7.29%
OCF growth 1Y-98.99%
OCF growth 3Y2.68%
OCF growth 5Y5.3%